Abderrahim El Guerrab

404 total citations
8 papers, 305 citations indexed

About

Abderrahim El Guerrab is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Abderrahim El Guerrab has authored 8 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Abderrahim El Guerrab's work include HER2/EGFR in Cancer Research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer-related Molecular Pathways (2 papers). Abderrahim El Guerrab is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer-related Molecular Pathways (2 papers). Abderrahim El Guerrab collaborates with scholars based in France. Abderrahim El Guerrab's co-authors include Frédérique Penault‐Llorca, Yves‐Jean Bignon, Mahchid Bamdad, Corinne Aubel, Fabrice Kwiatkowski, Anne Cayre, Fabrice Rossignol, Fabien Marchand, Alain Eschalier and Maryse Chalus and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Scientific Reports.

In The Last Decade

Abderrahim El Guerrab

8 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abderrahim El Guerrab France	8	149	132	60	60	32	8	305
Keren Zhang China	10	197 1.3×	70 0.5×	100 1.7×	91 1.5×	25 0.8×	19	353
Miguel Burgos Spain	14	333 2.2×	133 1.0×	32 0.5×	52 0.9×	32 1.0×	27	514
Ivanda Pavlovska United States	3	219 1.5×	158 1.2×	26 0.4×	38 0.6×	21 0.7×	3	355
Huanling Lai China	11	186 1.2×	65 0.5×	47 0.8×	73 1.2×	15 0.5×	26	370
Mandar Bhonde India	11	213 1.4×	151 1.1×	23 0.4×	67 1.1×	23 0.7×	25	433
Hailin Zou China	10	274 1.8×	94 0.7×	36 0.6×	68 1.1×	17 0.5×	20	400
Muhlis Akman Italy	10	202 1.4×	105 0.8×	53 0.9×	134 2.2×	35 1.1×	14	453
Wioletta Zielińska Poland	12	216 1.4×	65 0.5×	35 0.6×	70 1.2×	15 0.5×	29	437
Ruifang Guo China	14	225 1.5×	100 0.8×	33 0.6×	105 1.8×	55 1.7×	24	412

Countries citing papers authored by Abderrahim El Guerrab

Since Specialization

Citations

This map shows the geographic impact of Abderrahim El Guerrab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abderrahim El Guerrab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abderrahim El Guerrab more than expected).

Fields of papers citing papers by Abderrahim El Guerrab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abderrahim El Guerrab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abderrahim El Guerrab. The network helps show where Abderrahim El Guerrab may publish in the future.

Co-authorship network of co-authors of Abderrahim El Guerrab

This figure shows the co-authorship network connecting the top 25 collaborators of Abderrahim El Guerrab. A scholar is included among the top collaborators of Abderrahim El Guerrab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abderrahim El Guerrab. Abderrahim El Guerrab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Guerrab, Abderrahim El, Mahchid Bamdad, Yves‐Jean Bignon, Frédérique Penault‐Llorca, & Corinne Aubel. (2020). Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells. Scientific Reports. 10(1). 6367–6367. 52 indexed citations

Briat, Arnaud, Abderrahim El Guerrab, Fabrice Kwiatkowski, et al.. (2019). Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance.. PubMed. 9(5). 1043–1060. 38 indexed citations

Aissouni, Youssef, Abderrahim El Guerrab, Jérémy Ferrier, et al.. (2017). Acid-Sensing Ion Channel 1a in the amygdala is involved in pain and anxiety-related behaviours associated with arthritis. Scientific Reports. 7(1). 43617–43617. 23 indexed citations

Guerrab, Abderrahim El, Anne Cayre, Fabrice Kwiatkowski, et al.. (2017). Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer. PLoS ONE. 12(4). e0175960–e0175960. 13 indexed citations

Guerrab, Abderrahim El, Mahchid Bamdad, Yves‐Jean Bignon, Frédérique Penault‐Llorca, & Corinne Aubel. (2016). Anti‐EGFR monoclonal antibodies enhance sensitivity to DNA‐damaging agents in BRCA1‐mutated and PTEN‐wild‐type triple‐negative breast cancer cells. Molecular Carcinogenesis. 56(5). 1383–1394. 14 indexed citations

Guerrab, Abderrahim El, Mahchid Bamdad, Fabrice Kwiatkowski, et al.. (2016). Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer. Oncotarget. 7(45). 73618–73637. 87 indexed citations

Ferrier, Jérémy, Mathilde Bayet‐Robert, Abderrahim El Guerrab, et al.. (2015). Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception. Journal of Neuroscience. 35(50). 16418–16430. 46 indexed citations

Guerrab, Abderrahim El, et al.. (2011). Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer. PLoS ONE. 6(9). e25080–e25080. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact